Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age. (Q47621235)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age. |
scientific article |
Statements
1 reference
Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age. (English)
1 reference
Christina Zacharatou Jarlskog
1 reference
Harald Paganetti
1 reference
18 June 2008
1 reference
72
1 reference
1
1 reference
228-235
1 reference
Identifiers
1 reference
1 reference